You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative neoplasms research consortium

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

Recruiting
  • Accelerated/Blast-phase Myeloproliferative Neoplasm
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 9, 2022

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Healthy Volunteers of Fanconi Anemia, Myeloproliferative

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • microarray analysis
  • +8 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Jun 30, 2022

Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 19, 2022

Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +9 more
Aug 30, 2021

Magnetic Resonance Imaging Data for Breast Cancer Screening in

Active, not recruiting
  • Breast Cancer
  • No intervention.
  • Aachen, NRW, Germany
  • +1 more
Jan 16, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

NSCLC Trial in United States (Imprime PGG, MK-3475)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Chicago, Illinois
  • +4 more
Oct 6, 2022

Advanced Kidney Cancer, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in United States (Guadecitabine, Durvalumab)

Active, not recruiting
  • Advanced Kidney Cancer
  • +2 more
  • Chicago, Illinois
  • +4 more
Feb 16, 2022

Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

Recruiting
  • Myeloproliferative Neoplasms
  • Birmingham, Alabama
  • +16 more
Jan 27, 2023

Oncology Trial in Los Altos

Recruiting
  • Oncology
    • Los Altos, California
      Cancer Commons
    Jan 31, 2023

    Myeloproliferative Tumors Trial (INCA033989)

    Not yet recruiting
    • Myeloproliferative Neoplasms
    • (no location specified)
    Sep 11, 2023

    Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

    Active, not recruiting
    • Chronic Myeloproliferative Neoplasms
    • Berlin, Germany
    • +14 more
    Jun 14, 2021

    Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 25, 2023

    Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

    Not yet recruiting
    • Myeloproliferative Neoplasms (MPNs)
    • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
    • (no location specified)
    Mar 24, 2023

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in United States (PRT1419)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Orange City, Florida
    • +7 more
    Oct 31, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +3 more
    • Tampa, Florida
    • +5 more
    Jan 14, 2022

    Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

    Not yet recruiting
    • Male Breast Cancer
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Aug 12, 2022

    Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

    Recruiting
    • Myeloproliferative Neoplasm
    • Fedratinib Pill
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2022

    Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

    Completed
    • Primary Myelofibrosis
    • Anemia
    • Phoenix, Arizona
    • +24 more
    Aug 17, 2022

    Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

    Recruiting
    • Myeloproliferative Neoplasms
    • Herston, Queensland, Australia
    • +22 more
    Jun 30, 2023

    Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Allogeneic Bone Marrow Transplantation
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 13, 2021